Advanced search
Publication Cover
Climacteric Volume 7, 2004 - Issue 3
Submit an article Journal homepage
49
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Breast cancer in premenopausal women: recurrence and survival rates and relationship to hormone replacement therapy

EM Durna School of Women's and Children's Health, University of New South Wales, Sydney
,
GZ Heller Department of Statistics, Macquarie University, Sydney
,
LR Leader School of Women's and Children's Health, University of New South Wales, Sydney
,
P Sjoblom School of Women's and Children's Health, University of New South Wales, Sydney
,
JA Eden School of Women's and Children's Health, University of New South Wales, Sydney
&
BG Wren Barbara Gross Research Unit, Sydney Menopause Centre, Royal Hospital for Women, Sydney, Australia
Pages 284-291 | Received 13 Oct 2003, Accepted 29 Jan 2004, Published online: 27 Apr 2010

References

  • Writing Group for the Women's Health Initia-tive Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal wo-men. Principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321–33
  • Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419–27
  • Roy JA, Sawka CA, Pritchard KI. Hormone replacement therapy in women with breast cancer: do the risks outweigh the benefits? J Clin Oncol 1996;14:997–1006
  • Rostom AY. The management of menopausal sequelae in patients with breast cancer. Clin Oncol 2001;13:174–80
  • Beckman MW, Jap D, Djahansouzi S, et al. Hormone replacement therapy after treatment of breast cancer: effects on postmenopausal symp-toms, bone mineral density and recurrence rates. Oncology 2001;60:199–206
  • Eden JA, Bush T, Nand S, et al. A case-control study of combined continuous estrogen—proges-tin replacement therapy among women with personal history of breast cancer. Menopause 1995;2:67–72
  • Eden JA, Wren BG. Hormone replacement therapy after breast cancer: a review. Cancer Treat Rev 1996;22:335–43
  • Dew J, Eden J, Beller E, et al. A cohort study of hormone replacement therapy given to women previously treated for breast cancer. Climacteric 1998;1:137–42
  • Marsden J, Baum M, Sacks NPM. Hormone replacement therapy in women with previous breast cancer. Trends Endo crinol Metab 1998;9:32–8
  • Vassilopolou-Sellin R, Asmar L, Hortobagyi GN, et al. Estrogen replacement therapy after localised breast cancer: clinical outcome of 319 women followed prospectively. J Clin Oncol 1999;17: 1482–7
  • Natrajan PK, Soumakis K, Gambrell RD. Estro-gen replacement therapy in women with previous breast cancer. Am J Obstet Gynecol 1999;181:288–95
  • Natrajan PK, Puthugramam K, Gambrell RD. Estrogen replacement therapy in patients with early breast cancer. Am J Obstet Gynecol 2002;187:289–95
  • Urgis-Vrkaj M, Bebar S. A case-control study of hormone replacement therapy after primary surgical breast cancer treatment. Eur J Surg Oncol 1999;25:146–51
  • O'Meara ES, Rossing MA, Daling JR, et al. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J Nail Cancer Inst 2001;93:754–62
  • Col NF, Hirota LK, Orr RK, et al. Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk. J Clin Oncol 2001;19:2357–63
  • Peters GN, Fodera T, Sabol J, et al. Estrogen replacement therapy after breast cancer: a 12-year follow-up. Ann Surg Oncol 2001;8:828–32
  • Durna EM, Wren BG, Heller GZ, et al. Hormone replacement therapy after a diagnosis of breast cancer: cancer recurrence and mortal-ity. Med J Aust 2002;177:347–51
  • De La Rochefordiere A, Asselain B, Campana F, et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet 1993;341:1039–43
  • Lethaby A, Farquhar C, Sarkis A, Roberts H, Jepson R, Barlow D. Hormonal replacement therapy in menopausal women: endometrial hypoplasia and irregular bleeding. Cochrane Database Syst Rev 2000;2:CD000402
  • Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flushes in survivors of breast cancer: a randomised con-trolled trial. Lancet 2000;356:2059–63
  • Norman SG, Studd JW. A survey of views on hormone replacement therapy. Br J Obstet Gynaecol 1994;101:879–87
  • Dennerstein L, Shelley J, Smith AM, Ryan M. Hysterectomy experience among mid-aged Aus-tralian women. Med J Aust 1994;161:311–13
  • Lee CG, McCormick B, Mazumdar M, et al. Infiltrating breast carcinoma in patients age 30 years and younger: long term outcome for life, relapse and second primary tumors. Int J Radiat Oncol Biol Phys 1992;23:969–75
  • Durna EM, Crowe SM, Leader LR, et al. Quality of life of breast cancer survivors: the impact of hormonal replacement therapy. Climacteric 2002;5:266–76
  • Vassilopoulou-Selin R, Zolinski C. Estrogen replacement therapy in women with breast cancer: a survey of patient attitudes. Am J Med Sci 1992;304:145–9
  • Clayden JR, Bell JW, Pollard P. Menopausal flushing: double-blind trial of a non-hormonal medication. Br Med J 1974;1:409–12
  • Clemons M, Danson S, Howell A. Tamoxifen (`Nolvadex'): a review. Cancer Treat Rev 2002;28:165–80

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.